OPTIMIZATION OF DIAGNOSIS AND PROGNOSIS OF THE COURSE OF BRONCHOPULMONARY PATHOLOGIES IN CHILDREN, TAKING INTO ACCOUNT METABOLIC DISORDERS

Mualliflar

  • Muruvvat Akbarova Pharmacology, Physiology Department, Assistant Professor Muallif

Abstrak

Bronchopulmonary dysplasia, the most common received morbidity of preterm infants, is a extreme structure of continual lung disorder and is usually characterised through the presence of continual respiratory insufficiency and a supplemental oxygen requirement at 28 days of life with constant radiologic adjustments or persevering with need for oxygen therapy at 36 weeks’ postmenstrual age.

Iqtiboslar

Chengyin Y. Progressive Metabolic Abnormalities Associated with the Development of Neonatal Bronchopulmonary Dysplasia. Published online 2022.

What is bronchopulmonary dysplasia? https://www.hopkinsmedicine.org.

Asfia Banu Pasha. Bronchopulmonary dysplasia: Pathogenesis and treatment. Published online 2018.

Nashr qilingan

2024-01-31

Iqtibos keltirish tartibi

OPTIMIZATION OF DIAGNOSIS AND PROGNOSIS OF THE COURSE OF BRONCHOPULMONARY PATHOLOGIES IN CHILDREN, TAKING INTO ACCOUNT METABOLIC DISORDERS. (2024). Zamonaviy Dunyoda Innovatsion Tadqiqotlar, 3(1), 139-140. https://in-academy.uz/index.php/ZDIT/article/view/16469